» Articles » PMID: 9419219

Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

Overview
Journal J Exp Med
Date 1998 Jan 31
PMID 9419219
Citations 557
Authors
Affiliations
Soon will be listed here.
Abstract

T helper cells type 1 (Th1s) that produce interferon-gamma predominantly mediate cellular immune responses and are involved in the development of chronic inflammatory conditions, whereas Th2s which produce large amounts of IL-4 and IL-5 upregulate IgE production and are prominent in the pathogenesis of allergic diseases. The precise factors determining whether Th1- or Th2-mediated immune responses preferentially occur at a peripheral site of antigen exposure are largely unknown. Chemokines, a superfamily of polypeptide mediators, are a key component of the leukocyte recruitment process. Here we report that among four CXC (CXCR1-4) and five CC (CCR1-5) chemokine receptors analyzed, CXCR3 and CCR5 are preferentially expressed in human Th1s. In contrast, Th2s preferentially express CCR4 and, to a lesser extent, CCR3. In agreement with the differential chemokine receptor expression, Th1s and Th2s selectively migrate in response to the corresponding chemokines. The differential expression of chemokine receptors may dictate, to a large extent, the migration and tissue homing of Th1s and Th2s. It may also determine different susceptibility of Th1s and Th2s to human immunodeficiency virus strains using different fusion coreceptors.

Citing Articles

Compositional variation in eye-infiltrating immune cells distinguishes human uveitis subtypes.

Concepcion C, Xia Y, Korshunova Y, Bligard G, Taylor A, Paley M iScience. 2025; 28(3):111928.

PMID: 40060903 PMC: 11889669. DOI: 10.1016/j.isci.2025.111928.


Single cell suppression profiling of human regulatory T cells.

Sondergaard J, Tulyeu J, Priest D, Sakaguchi S, Wing J Nat Commun. 2025; 16(1):1325.

PMID: 39900891 PMC: 11791207. DOI: 10.1038/s41467-024-55746-1.


Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis.

Peker I, Icli H, Mutluay B, Yuksel B, Ozdemir Z, Koseoglu M Biomedicines. 2025; 13(1).

PMID: 39857624 PMC: 11762492. DOI: 10.3390/biomedicines13010040.


Autoimmune-Like Mechanism in Heart Failure Enables Preventive Vaccine Therapy.

Martini E, Cremonesi M, Felicetta A, Serio S, Puccio S, Pelamatti E Circ Res. 2024; 136(1):4-25.

PMID: 39629560 PMC: 11692788. DOI: 10.1161/CIRCRESAHA.124.324999.


Chemokines Signature and T Cell Dynamics in Leishmaniasis: Molecular insight and therapeutic application.

Upadhyay S, Kumar S, Singh V, Tiwari R, Kumar A, Sundar S Expert Rev Mol Med. 2024; 1-55.

PMID: 39587036 PMC: 11707835. DOI: 10.1017/erm.2024.36.


References
1.
Rogge L, Biffi M, Passini N, Presky D, Gubler U, Sinigaglia F . Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med. 1997; 185(5):825-31. PMC: 2196163. DOI: 10.1084/jem.185.5.825. View

2.
Springer T . Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994; 76(2):301-14. DOI: 10.1016/0092-8674(94)90337-9. View

3.
Lichtman A, Abbas A . T-cell subsets: recruiting the right kind of help. Curr Biol. 1997; 7(4):R242-4. DOI: 10.1016/s0960-9822(06)00111-4. View

4.
Karpus W, Lukacs N, Kennedy K, Smith W, Hurst S, Barrett T . Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol. 1997; 158(9):4129-36. View

5.
Baggiolini M, DEWALD B, Moser B . Human chemokines: an update. Annu Rev Immunol. 1997; 15:675-705. DOI: 10.1146/annurev.immunol.15.1.675. View